PURE Bioscience is at the forefront of technology-based life sciences/bioscience product development for a variety of end markets, with safe, non-toxic, and yet extremely effective proprietary technologies engineered and marketed to address a whole range of global health problems, including resistant pathogens like MRSA, in addition to other bacterial, fungal, and viral agents (including Avian Influenza, H1N1, HIV, Norovirus, and Influenza A).
PURE’s globally patented silver dihydrogen citrate (SDC) molecule (electrolytically generated stabilized ionic silver) is a perfect example of the cutting-edge bioscience work being done by the company, as this novel molecule achieves a two-pronged assault on microbial organisms through its dual modes of action while remaining very safe. First, by being recognized as food (citric acid) and entering the organism like a Trojan Horse via membrane transport proteins where it binds to DNA, as well as intra-cellular proteins, causing irreversible damage that results in death to the organism as its metabolic and reproductive capabilities disintegrate . Secondly, by attaching to and slicing open the outer membrane of the organism itself, resulting lysis (destruction and decomposition) of the membrane effectively tears the organism open causing death. Furthermore, the surplus of residual antimicrobial background noise shields cells with the broad-spectrum antibacterial, antifungal, and antiviral power of this revolutionary molecule.
The Oct 3 announcement that the company has started directly testing SDC-based formulas in food applications, so as to determine efficacy in fighting off the typical food borne pathogens like E. coli, Listeria, and Salmonella, extends the already obtained generally recognized as safe (GRAS) designation for SDC in food contact surface usage. The company is already well known among janitorial service providers, consumers, and chemical distributors for their surface disinfectants, like the EPA-registered PURE Hard Surface™ product (the Multi‐Purpose Cleaner Concentrate and Floor Cleaner Concentrate products round out the disinfectant lineup). SDC is colorless, odorless, non-caustic, and tasteless, in addition to being perfect for mixing as an additive or component in other, novel products, because its aqueous base formulates exceptionally well with other compounds. Such SDC-based products already represent a handsome revenue stream for PURE, and with demonstrated capabilities like being able to kill germs within 30 seconds of contact with a low toxicity profile, the established consumer base should grow fast as new avenues open up.
Another key aspect of SDC is that it does not induce bacterial resistance, which is absolutely paramount with the emergence of MRSA’s, H1N1, and other rapidly evolving problems on the global health front. Because SDC decimates harmful bacteria, fungi, and viral agents, yet is non-toxic to animals and humans alike, the end markets for both the surface disinfectants and varying SDC concentrates may indeed show rapidly increasingly uptake, especially as other products continue to be developed from the technology platform. PURE’s strategy of pursuing approvals via the FDA in partnership with third-party pharmaceutical companies to develop new SDC-based products takes advantage of the partner’s ability to handle testing and regulatory process work. PURE currently has an IND for a hand sanitizer in the works, in addition to products being developed for the dermatology, dental, wound care, and medical biofilm control markets.
PURE is very excited about the market potential for SDC-based formulations in direct food application roles and the promising results from initial tests performed at Deibel Laboratories has led to additional testing currently being carried out at the University of Georgia on lettuces. The plan is to test, validate, and optimize specific formulas that will collectively constitute a real gauntlet of a food processing program, which harmful agents will be forced to run and perish by. A full-spectrum farm-to-fork solution looks to be within striking distance for the company and the ideal characteristics/properties of SDC lend themselves naturally to such an application.
PURE shares have seriously rallied in recent weeks, jumping sharply on the good news about SDC testing in produce. The stock was up 52.43% from Oct 3 to the Oct 11 close at $1.57. Big moves for the company further charged with kinetic energy by the announcement from last month that Italian consortium TICE (The Italian Consortium Export) was named PURE’s general sales agent and distributor for all of Italy. This move to import into Italy and the associated sales effort has already generated considerable bounce from interests in food processing, food service, general commercial, and retail throughout the company’s business network.
It’s easy to fall in love with this kind of technology, because while the efficacy of traditional silver-based disinfectants is well established, most of them have such short shelf lives (usually only hours or days) that the logistics were never really there to execute commercially across so wide an arc of potential applications the way SDC-based formulations can. Not only does the unique bond of the silver ion in SDC maintain optimum bioavailability for the silver, the silver ion complex remains stable in solution and has a shelf life of several years.
Think for a second about all the industries this technology can impact, from industrial applications in agribusiness, hydrocarbon development, water treatment, and textiles, to the obvious cleaning roles in food, healthcare, and personal/pet care. Even sweeping potential in the preservatives space is clearly on the horizon. The company currently holds a series of patents in these areas in nearly all key global regions (with the remainder being addressed).
PURE will be looking to find new partners moving forward to explore the vast potential of SDC in produce and food processing as the company gathers relevant data for FDA/EPA clearances, making huge strides in the agricultural market and food processing industry at the same time as the true power of the company’s technology is demonstrated in detail.
For more information on PURE Bioscience, Inc., please visit the company’s website at: www.PureBio.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
